Target intelligence / Profile preview

H3-3A divergent transcript (H3-3A-DT)

Target
H3-3A-DT
Molecular classification
Long non-coding RNA (lncRNA), Divergent transcript, Other
01

Overview

The H3-3A divergent transcript (H3-3A-DT) is a long non-coding RNA (lncRNA) transcribed in a direction divergent from the protein-coding H3-3A gene, which encodes the histone variant H3.3A. Divergent transcripts such as H3-3A-DT are often associated with active promoter regions and are part of the complex transcriptional landscape of the genome, reflecting underlying regulatory mechanisms. Such transcripts can be involved in local chromatin regulation or gene expression fine-tuning, but their precise functions are frequently uncharacterized and they are not considered therapeutic targets. If you are seeking a histone protein, you may have meant "H3-3A" (the histone H3.3A protein), not "H3-3A-DT" (the divergent transcript/lncRNA). Note: If you are interested in the H3-3A histone protein (which is part of the H3.3 family and involved in key chromatin and epigenetic functions), that is a distinct target with much broader biological and disease relevance. Please clarify if this is the intended target, as "H3-3A-DT" is not a standard drug development target.

Other names
H3-3A divergent transcriptH3-3A-DT RNAH3-3A-DT lncRNAH3-3A divergent non-coding transcript
02

Mechanism of action

Not applicable—as H3-3A-DT is a non-coding RNA transcript, there are no known drugs with defined mechanisms of action via this target.

03

Biological functions

Transcriptional regulation (as a divergent transcript associated with active promoters and chromatin modifications)Chromatin remodeling (by association with the H3-3A locus)Possibly involvement in epigenetic regulationOther
04

Disease associations

No direct disease association documented for H3-3A-DT itself. Dysregulation of divergent promoter transcription and associated lncRNAs can sometimes contribute to altered transcriptional states seen in cancer or developmental disorders, but no specific role attributed to this transcript.

Beyond the preview

Go deeper on H3-3A divergent transcript (H3-3A-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on H3-3A divergent transcript (H3-3A-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call